• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN LLC VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN LLC VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT Back to Search Results
Model Number VS-402
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Reaction (2414)
Event Date 11/16/2016
Event Type  Injury  
Manufacturer Narrative
A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
The physician used a venaseal closure system during procedure for treatment of the great saphenous vein (gsv).The lumen was flushed prior to use.The ifu was followed.Local anesthesia and transducer compression was used.Two (2) segments of the vessel were treated.The vein closed.Procedure was completed.Following treatment of venous disease with venaseal, the patient had a fever, and body aches and severe redness surrounding the treated vein.The physician prescribed erythromycin which resolved the redness.Physician felt this is an indication that the patient had strep.The patient¿s condition is improving.
 
Manufacturer Narrative
Additional information received: it was reported that the patient¿s symptoms began within 72 hours of the procedure, before the 72 hour dvt rule out ultrasound.It was reported that the symptoms cleared up with the antibiotic, erythromycin, given.It is unknown how long after the patient began the antibiotic that it resolved.It was reported that the physician did not culture the infection however it resolved with the erythromycin antibiotic which is used for strep infections.Consequently, the physician is confident that it was strep the patient contacted and that the infection was unrelated to the venaseal.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENA SEAL CLOSURE SYSTEM
Type of Device
AGENT, OCCLUDING, VASCULAR, PERMANENT
Manufacturer (Section D)
COVIDIEN LLC
951 aviation parkway
morrisville NC 27560
Manufacturer (Section G)
COVIDIEN LLC
951 aviation parkway
morrisville NC 27560
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key6173452
MDR Text Key62338601
Report Number3011410703-2016-00022
Device Sequence Number1
Product Code PJQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,consum
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 12/20/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberVS-402
Device Lot NumberASKU
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/16/2016
Initial Date FDA Received12/14/2016
Supplement Dates Manufacturer ReceivedNot provided
12/20/2016
Supplement Dates FDA Received01/17/2017
09/28/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-